CSIMarket Company Name, Ticker, Competitors, else..


Quince Therapeutics Inc   (NASDAQ: QNCX)
Other Ticker:  
 

Quince Therapeutics Inc

QNCX's Fundamental analysis



Quince Therapeutics Inc 's sales fell in the first quarter of 2025 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 12.78 %

Quince Therapeutics Inc net loss increased from $0 millions, to $-15 millions in first quarter of 2025,

• More on QNCX's Growth


Quince Therapeutics Inc
realized a net loss in trailing twelve months.

Quince Therapeutics Inc realized cash reduction of $ -0.32 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.45.


• More on QNCX's Valuation
 
 Total Debt (Millions $) 15
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -1.00

Quince Therapeutics Inc
realized net loss in trailing twelve months.

Quince Therapeutics Inc realized cash outflow of $ -0.32per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.45.

Quince Therapeutics Inc Price to Book Ratio is at 4.33 lower than Industry Avg. of 2026.67. and higher than S&P 500 Avg. of 0.01

• More on QNCX's Valuation

•  Market Capitalization (Millions $) 80
•  Shares Outstanding (Millions) 44
•  Employees 36
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -15
•  Cash Flow (TTM) (Millions $) -14
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) 15
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) -1.00

•  Market Capitalization (Millions $) 80
•  Shares Outstanding (Millions) 44
•  Employees 36
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -15
•  Cash Flow (TTM) (Millions $) -14
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 4.05
•  Total Debt to Equity (MRQ) 0.82
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com